Abstract
Fluorescent proteins have revolutionized in vivo biology. Due to their intrinsic brightness, multiple colors, and ease of genetic manipulation, fluorescent proteins have been demonstrated to be the reporters of choice for in vivo imaging. The present report reviews applications of fluorescent proteins for imaging cancer progression, gene expression, angiogenesis, stem cells, bacterial infection, Leishmania infection, and asthma, at the cellular and subcellular level in live mice. With fluorescent-protein-expressing cells and a highly sensitive small animal imaging system, cellular and subcellular dynamics can now be observed in live mice in real time. Such imaging possibilities can provide new visual targets for novel drug therapy. Fluorescent proteins thus enable both micro as well as macro imaging technology and thereby provide the basis for the new field of in vivo cell biology.
Keywords: Asthma, cancer, cellular dynamics, fluorescence imaging, GFP, infection, live mice, metastatic trafficking, nuclear dynamics, RFP, fluorescent-protein-expressing cells, visual drug targets, Fluorescent proteins, stem cells, dual-color cells
Current Pharmaceutical Biotechnology
Title: Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins
Volume: 13 Issue: 4
Author(s): Robert M. Hoffman
Affiliation:
Keywords: Asthma, cancer, cellular dynamics, fluorescence imaging, GFP, infection, live mice, metastatic trafficking, nuclear dynamics, RFP, fluorescent-protein-expressing cells, visual drug targets, Fluorescent proteins, stem cells, dual-color cells
Abstract: Fluorescent proteins have revolutionized in vivo biology. Due to their intrinsic brightness, multiple colors, and ease of genetic manipulation, fluorescent proteins have been demonstrated to be the reporters of choice for in vivo imaging. The present report reviews applications of fluorescent proteins for imaging cancer progression, gene expression, angiogenesis, stem cells, bacterial infection, Leishmania infection, and asthma, at the cellular and subcellular level in live mice. With fluorescent-protein-expressing cells and a highly sensitive small animal imaging system, cellular and subcellular dynamics can now be observed in live mice in real time. Such imaging possibilities can provide new visual targets for novel drug therapy. Fluorescent proteins thus enable both micro as well as macro imaging technology and thereby provide the basis for the new field of in vivo cell biology.
Export Options
About this article
Cite this article as:
M. Hoffman Robert, Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins, Current Pharmaceutical Biotechnology 2012; 13 (4) . https://dx.doi.org/10.2174/138920112799436311
DOI https://dx.doi.org/10.2174/138920112799436311 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations
Recent Patents on Drug Delivery & Formulation Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) History and Milestones of Mouse Models of Autoimmune Diseases
Current Pharmaceutical Design Vascular Adenosine Receptors; Potential Clinical Applications
Current Vascular Pharmacology Antagonism of Eosinophil Accumulation in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
Current Pharmaceutical Design Role of Radiopharmaceuticals in Development of Inhaled Drugs
Current Pharmaceutical Design Hypersensitivity Reactions to Complementary and Alternative Medicine Products
Current Pharmaceutical Design Bronchial Asthma and Lung Cancer
Current Respiratory Medicine Reviews Disruption of Circadian Rhythms in Critical Illness - A Role of Hyperoxia-Induced Lung Injury
Current Pharmaceutical Design New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry Inflammation in Asthma Pathogenesis: Role of T Cells, Macrophages, Epithelial Cells and Type 2 Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Edema, Inflammation and Fibrosis – Comparison Between Catecholamine- and Hypoxia-Induced Pulmonary Injuries
Vascular Disease Prevention (Discontinued) Noninvasive Assessment of Cytokines in Occupational Respiratory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Is uPAR the Centre of a Sensing System Involved in the Regulation of Inflammation?
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Asthma-COPD Overlap (ACO) among Adult-onset Asthma Patients
Current Respiratory Medicine Reviews Editorial [Hot Topic: Modulation and New Mediators in Inflammation Executive (Guest Editor: Frank A. Redegeld)]
Current Pharmaceutical Design